MINI-SYMPOSIUM

Hibernation and heart failure

P G Camici

Correspondence to:
Correspondence to:
Paolo G Camici MD
MRC Clinical Sciences Centre, Hammersmith Hospital, Ducane Road, London W12 ONN, UK; paolo.camici@csc.mrc.ac.uk

Keywords: Hibernation; heart failure

Abbreviations: MBF, myocardial blood flow; NYHA, New York Heart Association; PET, positron emission tomography; SPECT, single photon emission computed tomography

The first 150 words of the full text of this article appear below.

Heart failure accounts for approximately 20% of all hospital admissions among people over 65, and in the past 10 years the hospitalisation rate has increased by almost 160%.¹ Although different large randomised trials carried out during the past two decades have demonstrated a significant reduction in mortality for heart failure patients treated medically, symptomatic heart failure continues to have a one year mortality close to 45%.²³

In an effort to improve the early recognition of heart failure, the American College of Cardiology and the American Heart Association have recently proposed a new approach to the classification of heart failure based on four progressive stages.⁴ This new categorisation emphasises the evolution and progression of heart failure and is quite different from the traditional New York Heart Association (NYHA) classification whose primary objective was to describe functional limitations. Although this recent classification underscores the risk factors and structural abnormalities, which are necessary . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough

R J Kim and D J Shah
Heart 2004 90: 137-140. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Mizuno, R, Fujimoto, S, Saito, Y, Nakamura, S (2009). Depressed recovery of subendocardial perfusion in persistent heart failure after complete revascularisation in diabetic patients with hibernating myocardium. Heart 95: 830-834 [Abstract] [Full Text]  
• Wang, Y.-X., Qian, L.-X., Liu, D., Yao, L.-L., Jiang, Q., Yu, Z., Gui, Y.-H., Zhong, T. P., Song, H.-Y. (2007). Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility. Cardiovasc Res 74: 290-303 [Abstract] [Full Text]  
• Hasegawa, H., Takano, H., Iwanaga, K., Ohtsuka, M., Qin, Y., Niitsuma, Y., Ueda, K., Toyoda, T., Tadokoro, H., Komuro, I. (2006). Cardioprotective Effects of Granulocyte Colony-Stimulating Factor in Swine With Chronic Myocardial Ischemia. J Am Coll Cardiol 47: 842-849 [Abstract] [Full Text]  
• Camici, P G (2005). Coronary recanalisation, myocardial viability, and ventricular remodelling after infarction. Heart 91: 421-422 [Abstract] [Full Text]